In breast cancer, carcinoembryonic antigen (CEA), cancer antigen 125 (CA125) and cancer antigen 15-3 (CA15-3) are the most widely used serum tumor markers in clinical routine, although their usefulness remains controversial [5, 7]. This evidence concerns the gene CEACAM5 and neoplasm.